Autolus Therapeutics
0 sources
Financials
0001730463-26-000038Autolus Therapeutics
Summary
Autolus Therapeutics is a business[1].
Key Facts
- Autolus Therapeutics is in the country of United Kingdom[2].
- Autolus Therapeutics is in the country of GB[3].
- Autolus Therapeutics's instance of is recorded as business[4].
- Autolus Therapeutics's instance of is recorded as public company[5].
- Autolus Therapeutics is owned by Syncona[6].
- Autolus Therapeutics is owned by PPF Capital Partners Fund[7].
- Autolus Therapeutics's stock exchange is recorded as Nasdaq[8].
- January 1, 2014 marks the founding of Autolus Therapeutics[9].
- 2018-02-02 marks the founding of Autolus Therapeutics[10].
- Autolus Therapeutics's coordinate location is recorded as {'lat': 51.514581, 'lon': -0.224554}[11].
- Autolus Therapeutics's official website is recorded as http://www.autolus.com/[12].
- Autolus Therapeutics's legal form is recorded as public limited company[13].
- Autolus Therapeutics's legal form is recorded as B6ES[14].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300C0KZP8EYROLL02[15]
-
Registered legal name: Autolus Therapeutics PLC[16]
-
Legal jurisdiction: GB[17]
-
GLEIF entity category: GENERAL[18]
-
Legal form (ISO 20275 ELF): B6ES[19]
-
Entity status: ACTIVE[20]
-
LEI registration status: ISSUED[21]
-
Entity created: 2018-02-02[22]
-
LEI first registered: 2018-05-15[23]
-
LEI last updated: 2026-03-15[24]
-
LEI next renewal: 2027-04-10[25]
-
Managing LOU: 5299000J2N45DDNE4Y28[26]
-
Registration authority: RA000585[27]
-
Authority entity ID: 11185179[28]
-
Conformity flag: NON_CONFORMING[29]
Body
Founding
Recorded inception include January 1, 2014[9] and 2018-02-02[10].
Ownership
Owners include Syncona[6], a business[30], in Guernsey[31], founded in 2012[32], headquartered in Saint Peter Port[33] and PPF Capital Partners Fund[7], a business[34], in Netherlands[35], founded in 2012[36], headquartered in Amsterdam[37]. Autolus Therapeutics's stock exchange is recorded as Nasdaq[8].